CG Oncology (CGON) Institutional Ownership

$25.84
-2.66 (-9.33%)
(As of 05/13/2024 ET)

Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)

Current
Institutional Ownership
Percentage
26.56%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$363.79M
Number of
Institutional Sellers
(last 12 months)
0
Get CGON Insider Trade Alerts

Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CGON Institutional Buying and Selling by Quarter

CG Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061%
5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%
5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460%
5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003%
5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%
5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%
5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028%
5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017%
(Data available from 1/1/2016 forward)

CGON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CGON shares?

During the previous two years, the following institutional investors and hedge funds held shares of CG Oncology shares: Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), American International Group Inc. ($13.44M), TimesSquare Capital Management LLC ($9.84M), StemPoint Capital LP ($1.79M), Capstone Investment Advisors LLC ($806K), and BNP Paribas Financial Markets ($492K).Learn more on CGON's institutional investors.

What percentage of CG Oncology stock is owned by institutional investors?

26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings.

Which institutional investors have been buying CG Oncology stock?

The following institutional investors have purchased CG Oncology stock in the last 24 months: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), American International Group Inc. ($306.23K), TimesSquare Capital Management LLC ($224.07K), StemPoint Capital LP ($40.72K), Capstone Investment Advisors LLC ($18.35K), and BNP Paribas Financial Markets ($11.20K).

How much institutional buying is happening at CG Oncology?

Institutional investors have bought a total of 8,286,722 shares in the last 24 months. This purchase volume represents approximately $363.79M in transactions.


This page (NASDAQ:CGON) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners